Loading...
Freedom of Information (FOI) NHS Lothian | Our Organisation
NOTE: 100 recent requests are displayed below. Use search to find older requests.
Freedom of Information Request Reference: 9949
Date Received: 03/04/2025
Summary:
I am analysing the treatment of dermatological conditions in the UK so how many patients were treated in the last 4 months (December 2024 to March 2025) by the dermatology department with each of the following products: • Abrocitinib • Baricitinib • Dupilumab • Lebrikizumab • Tralokinumab • Upadacitinib • Nemolizumab
Date of Response: 25/04/2025
View Response: 9949.pdf

Freedom of Information Request Reference: 9926
Date Received: 01/04/2025
Summary:
The average waiting time for an endoscopy in NHS Lothian; how many patients are currently waiting for one; and an average of many endoscopies are carried out each day. The average waiting time for an MRI scan in NHS Lothian; how many patients are currently waiting for one; and an average of many MRI scans are carried out each day.
Date of Response: 25/04/2025
View Response: 9926.pdf

Freedom of Information Request Reference: 9996
Date Received: 16/04/2025
Summary:
Request in relation to personal information.
Date of Response: 17/04/2025
View Response: 9996.pdf

Freedom of Information Request Reference: 9942
Date Received: 03/04/2025
Summary:
The number of people who have died after waiting more than four hours in A&E within your health board over the past five years (2019-20 and 2023-24), broken down by year. The number of people who have waited more than four hours in A&E within your health board over the past five years (2019-20 and 2023-24), broken down by year. If available, the longest recorded waiting time for a patient in A&E for each of the past five years (2019-20 and 2023-24).
Date of Response: 23/04/2025
View Response: 9942.pdf

Freedom of Information Request Reference: 9941
Date Received: 03/04/2025
Summary:
I would like to request the following: - minutes of the RIE (Little France) car parking appeals review meeting held on 1 April 2025 - the scoring criteria for awarding a parking permit to staff at the RIE - the number of staff parking permits rejected in the last 12 months at the RIE - the number of parking permits currently allocated to administrative, non-patient facing, non-shift working staff at the RIE (please also provide this as a % of total parking permits allocated).
Date of Response: 22/04/2025
View Response: 9941.pdf

Freedom of Information Request Reference: 9939
Date Received: 02/04/2025
Summary:
1. The number of women under the care of this health board who have travelled to England for abortion care from January 1, 2025, to the present date. 2. The gestational age of the pregnancies at the time of travel for abortion care. 3. The number of women who have died as a result of travelling to England for abortion care. 4. The gestation limit for providing abortion care in the health board (not the legal limit but the current care you can provide). 5. The number of staff members trained to provide abortion care up to the legal limit.
Date of Response: 23/04/2025
View Response: 9939.pdf

Freedom of Information Request Reference: 9934
Date Received: 02/04/2025
Summary:
1. Please can you confirm how many shifts have been released/allocated to ON framework agencies within the last 3 months? 2. In the last 3 months which wards, or departments were these ON framework requests for? 3. Please can you confirm how many shifts have been filled by ON framework agencies within the last 3 months? 4. Which on framework agencies are the Healthboard currently utilizing for nursing vacancies and what is the current spend on these agencies year to date? 5. Please can you confirm how many shifts have been released to OFF Framework agencies within the last 3 months? 6. What is the average charge rate for registered nurses, RMNs, and neonatal nurses from ON framework agencies? 7. Who at Staff Bank is responsible for onboarding ON framework agencies and could you provide me with their name and contact details such as their email? 8. How much was your Off-Framework agency spend for each of the following staff groups between 1st January 2025 – 1st March 2025 (a) RGN’s (b) Registered Midwives (c) RMN’s (d) A&E Nurses (e) ITU Nurse (f) Neonatal Nurse (g) Chemotherapy Nurse (h) Theatre Nurse 9. Following the same breakdown of staff groups in Question 8, how many Off-framework shifts have been unfilled between 1st January 2025 – 1st March 2025
Date of Response: 22/04/2025
View Response: 9934.pdf

Freedom of Information Request Reference: 9933
Date Received: 31/03/2025
Summary:
Request in relation to CCTV footage.
Date of Response: 04/04/2025
View Response: 9933.pdf

Freedom of Information Request Reference: 9929
Date Received: 01/04/2025
Summary:
I would be grateful if you could provide the following information: a) the total and b) the proportion of the health board’s budgeted spending (excluding capital spending) which was allocated to mental health services for the 2024-25 financial year.
Date of Response: 22/04/2025
View Response: 9929.pdf

Freedom of Information Request Reference: 9922
Date Received: 28/03/2025
Summary:
I would appreciate copies of the following: • Letters sent to expectant women advising of screening test results following combined or quadruple screening for Down Syndrome. If the content differs based on the likelihood of a high or low chance result, please provide examples of both. • Letters or result notifications from Non-Invasive Prenatal Testing (NIPT), including examples for both high and low chance results if they differ. • Any information shared with expectant women regarding these tests (combined/quadruple screening and NIPT), including letters, leaflets, or signposting materials. • Any materials provided to expectant women about Down Syndrome itself, including guidance on pregnancy and care following an antenatal diagnosis.
Date of Response: 18/04/2025
View Response: 9922.pdf

Freedom of Information Request Reference: 9921
Date Received: 28/03/2025
Summary:
2022/23, 2023/24, 2024/25, 2025/26 -The amount in total budgeted by the board for the provision of counselling services. -How much was spent on counselling services provided directly by the board. -How much was spent on the commissioning of counselling services from other organisations. -The names of organisations that were commissioned to provide counselling. -The number of counselling services opened by the board. -The number of counselling services closed by the board. -The amount forecast to be spent on counselling in 2026/27 by the board.
Date of Response: 16/04/2025
View Response: 9921.pdf

Freedom of Information Request Reference: 9917
Date Received: 27/03/2025
Summary:
1. How many patients are currently on a waiting list for audiology services within the Health Board? 2. What is the current average waiting time for first assessment by audiology services at the Health Board? 3. What is the current average waiting time for assessment to fitting of hearing aid(s) at the Health Board? 4. What is the current average waiting time for re-assessment by audiology services at the Health Board? 5. How many audiologists are currently working within the Health Board?
Date of Response: 21/04/2025
View Response: 9917.pdf

Freedom of Information Request Reference: 9916
Date Received: 27/03/2025
Summary:
When referring to a private patient this is a patient treated within NHS facilities but not funded by the NHS. 1. Oncology Services Please confirm the number of patients treated for cancer by patient type for the calendar year (2024). 2. Patients treated with immuno-oncology products Please provide the total number of patients who have been treated with an Immuno-oncology product latest calendar year (2024) by patient type. 3. Prescribing of specific Immuno-oncology products. For the latest calendar year (2024), please provide the number of patients treated with the following Immuno-oncology products: Pembrolizumab (Keytruda) Nivolumab (Opdivo) Nivolumab / Relatlimab (Opdualag)
Date of Response: 22/04/2025
View Response: 9916.pdf

Freedom of Information Request Reference: 9914
Date Received: 27/03/2025
Summary:
What was the total number of patient appointments facilitated via the NHS app for the trust during the past year? Considering the above, what is the total number of outpatient appointments booked by the trust for the previous year? What are the specific patient cohorts/clinical services that utilise NHS App bookings?
Date of Response: 14/04/2025
View Response: 9914.pdf

Freedom of Information Request Reference: 9913
Date Received: 27/03/2025
Summary:
1. Please provide answers to the following questions for your Health Board’s Radiology Information System (RIS). If your Health Board does not use a RIS, please state this. a) Which supplier? b) What is the name of the system? c) When was it installed (month and year)? d) When does the contract expire (month and year)? e) Is it annually renewed? f) What procurement framework do you use (e.g., tender)? g) What were the installation costs (in £)? h) What were the training costs (in £)? i) What are the annual maintenance costs (in £)? j) What is the annual spend on the RIS (in £)? k) What is the total value of the contract (in £)? l) Do you have any plans to replace the system (yes/no/maybe and why)? 2. Please provide answers to the following questions for your Health Board’s Picture Archiving and Communication System (PACS). If your Health Board does not use a PACS, please state this. a) Which supplier? b) What is the name of the system? c) When was it installed (month and year)? d) When does the contract expire (month and year)? e) Is it annually renewed? f) What procurement framework do you use (e.g., tender)? g) What were the installation costs (in £)? h) What were the training costs (in £)? i) What are the annual maintenance costs (in £)? j) What is the annual spend on the PACS (in £)? k) What is the total value of the contract (in £)? l) Do you have any plans to replace the system (yes/no/maybe and why)? 3. Please provide answers to the following questions for your Health Board’s Electronic Health Record (EHR). If your Health Board does not use an EHR, please state this. m) Which supplier? n) What is the name of the system? o) When was it installed (month and year)? p) When does the contract expire (month and year)? q) Is it annually renewed? r) What procurement framework do you use (e.g., tender)? s) What were the installation costs (in £)? t) What were the training costs (in £)? u) What are the annual maintenance costs (in £)? v) What is the annual spend on the EHR (in £)? w) What is the total value of the contract (in £)? x) Do you have any plans to replace the system (yes/no/maybe and why)?
Date of Response: 16/04/2025
View Response: 9913.pdf

Freedom of Information Request Reference: 9912
Date Received: 27/03/2025
Summary:
I am looking for information on whether the Trust has a MATTRESS RENTAL CONTRACT. 1. Does the Authority currently have any mattress contracts in place? If so, could you tell when this expires? 2. Could the Authority outline what assets are under the mattress contract? 3. Will the Authority look to put the contract out to tender after the expiry date?
Date of Response: 18/04/2025
View Response: 9912.pdf

Freedom of Information Request Reference: 9909
Date Received: 26/03/2025
Summary:
• Who holds health board wide responsibility for the maintenance of procedures and policies? o What is their name and email address? • What digital tools does the health board use for the staff to reference these procedures and policies? - ie - intranet • How does the health board record that staff have read and comply with the procedures and policies? • Which tools are used for on-boarding new staff in relation to reading procedures and policies? • How do the heads of department monitor that clinical and non clinical staff have read/understood mandatory procedural updates? • How many staff have accessed your NHS Intranet in the past year?
Date of Response: 18/04/2025
View Response: 9909.pdf

Freedom of Information Request Reference: 9908
Date Received: 26/03/2025
Summary:
Request in relation to IT infrastructure, including aspects of Database software, Wifi coverage, and Virtualisation.
Date of Response: 21/04/2025
View Response: 9908.pdf

Freedom of Information Request Reference: 9907
Date Received: 26/03/2025
Summary:
1/ How many children (aged under 18) have been treated for overdoses at hospitals in your board area involving paracetamol in 2022, 2023, 2024 and 2025 to date? Could this age be presented by year, intent (accidental and deliberate) and by age. 2/ How many children (aged under 18) have been treated for overdoses at hospitals in your board areainvolving illicit substances in 2022, 2023, 2024 and 2025 to date? Could this age be presented by year, intent (accidental and deliberate) and by age.
Date of Response: 21/04/2025
View Response: 9907.pdf

Freedom of Information Request Reference: 9906
Date Received: 26/03/2025
Summary:
Do any of the following clinical services operate from a “partially booked service” model?* Please provide the total number of patients who have been removed from the waiting list due to breach of the trusts access policy in the last year. General Surgery Service Urology Service Trauma and Orthopaedic Service Ear Nose and Throat Service Ophthalmology Service Oral Surgery Service Neurosurgical Service Plastic Surgery Service Cardiothoracic Surgery Service General Internal Medicine Service Gastroenterology Service Cardiology Service Dermatology Service Respiratory Medicine Service Neurology Service Rheumatology Service Elderly Medicine Service Gynaecology Service Other - Medical Services Other - Mental Health Services Other - Paediatric Services Other - Surgical Services Other - Other Services Radiology/Imaging Respiratory physiology - Sleep Studies Urodynamics - Pressures & Flows Endoscopy Trust Average
Date of Response: 22/04/2025
View Response: 9906.pdf

Freedom of Information Request Reference: 9904
Date Received: 25/03/2025
Summary:
1a: Are plastic bin liners used on psychiatric inpatient wards run by your Trust? b: If they are not allowed, when were they prohibited? c: How many incidents of inpatient self-harm involving plastic bin liners have there been in the last five years (specifically 2020, 2021, 2022, 2023 & 2024)? d: How many inpatient deaths involving plastic bin liners have there been in the last five years (specifically 2020, 2021, 2022, 2023 & 2024)? 2a: Are other types of plastic bags (i.e. not bin liners) allowed into psychiatric inpatient wards run by your Trust? b: If they are not allowed, when were they prohibited? c: How many incidents of inpatient self-harm involving plastic bags (excluding bin liners counted above) have there been in the last five years (specifically 2020, 2021, 2022, 2023 & 2024)? d: How many inpatient deaths involving plastic bags (excluding bin liners counted above) have there been in the last five years (specifically 2020, 2021, 2022, 2023 & 2024)?
Date of Response: 18/04/2025
View Response: 9904.pdf

Freedom of Information Request Reference: 9903
Date Received: 25/03/2025
Summary:
Please outline how many times in the last five years (since March 2020) that you have been contacted by a patient who has received private surgery while on the waiting list for elective surgery via your health board and who has requested your health board subsequently contribute towards the cost of the private surgery. Out of these claims, please outline how many times your health board has agreed to compensate for the surgery and how many it has refused. Please also provide a summary of what the elective surgery was for. Please also outline how many times since March 2020, where the Scottish Public Service Ombudsman has found that your health board should calculate and reimburse a patient who has received private surgery while awaiting NHS surgery. Please supply a financial figure as to how much money in total your health board has paid directly to patients who have received private surgery while awaiting elective surgery via your health board since March 2020.
Date of Response: 18/04/2025
View Response: 9903.pdf

Freedom of Information Request Reference: 9853
Date Received: 11/03/2025
Summary:
Do you provide nail management as part of your podiatry service for patients?
Date of Response: 08/04/2025
View Response: 9853.pdf

Freedom of Information Request Reference: 9827
Date Received: 04/03/2025
Summary:
1. The number of pagers/ beepers used within the health board and if possible, who this is used by, broken down by profession (e.g. doctors, nurses etc). 2. The yearly spend on pager/ beeper devices for each financial year from 2018/2019 to 2024/25. 3. The yearly spend on postage for each financial year from 2018/2019 to 2024/25. 4. The number of working fax machines within the health board which have been used within the past 2 years (2023 and 2024).
Date of Response: 23/04/2025
View Response: 9827.pdf

Freedom of Information Request Reference: 9816
Date Received: 04/03/2025
Summary:
1. The name, job title and email address of the individual responsible for adult psychological therapies? 2. The name, job title and email address of the individual responsible for CAMHS? 3. The name, job title and email address of the individual responsible for Neurodevelopmental assessments in adults? 4. The name, job title and email address of the individual responsible for Neurodevelopmental assessments in children?
Date of Response: 26/03/2025
View Response: 9816.pdf

Freedom of Information Request Reference: 9782
Date Received: 24/02/2025
Summary:
The person who holds the following job title or responsibilities within your organisation. Please could you include their Job title, name and email address. 1. Director of Digital 2. Director of Digital Transformation 3. Chief Information Officer 4. Director of Information Technology 5. Chief Clinical Information Officer 6. Head of Information Technology 7. Digital Innovations Lead 8. Associate Director of Informatics – Infrastructure 9. Digital Systems Technical Lead 10. Deputy Digital Portfolio Director 11. Director of Improvement and Integration 12. Head of ICT Operations 13. Digital Services Project Manager 14. Chief Digital Information Officer 15. Chief Nursing Information Officer 16. Digital Applications Manager 17. Digital Services Manager 18. Head of Information and Performance
Date of Response: 24/03/2025
View Response: 9782.pdf

Freedom of Information Request Reference: 9750
Date Received: 14/02/2025
Summary:
(a) whether any of these practices open seven or even just six days per week; (b) the minimum number of doctors (and ancillary staff such as nurses and administrative staff) to be employed by the practice*; (c) the minimum number of doctors to be on duty at any one given time*; (d) the amount of hours per week to be worked by each doctor*; . (e) the minimum total number of hours to be worked per week by the total number of doctors in the practice*; (f) what arrangements should be made for locum doctors to substitute regular doctors when these are on holiday or are otherwise unavailable (g) whether the practice should accept requests for appointments submitted by e-mail and how these should be responded to.
Date of Response: 28/02/2025
View Response: 9750.pdf

Freedom of Information Request Reference: 9748
Date Received: 14/02/2025
Summary:
I would like to know the following: • Does your health board have the "Discharge to Assess" or "Home First" model? • If so, please provide description of the model
Date of Response: 22/04/2025
View Response: 9748.pdf

Freedom of Information Request Reference: 9670
Date Received: 27/01/2025
Summary:
To ask, in your health board area, how many people are currently on waiting lists for an appointment or consultation in relation to eating disorders. Could this be broken down by gender and by under 18s v over 18s.
Date of Response: 21/02/2025
View Response: 9670.pdf

Freedom of Information Request Reference: 9899
Date Received: 24/03/2025
Summary:
1. The total number of critical care beds (ICU) available within your health board area, please break this down by the number of beds at each hospital 2. The total number of critical care beds (ICU) available within your health board area as of January 1st of each of the past 5 years (2021-2025). Please break this down by number of beds available each year 3. Monthly or weekly data on critical care bed (ICU) availability for patients for each month in the past 12 months (March 1st 2024 - March 1st 2025) 4. Monthly or weekly data on critical care bed (ICU) occupancy for each month in the past 12 months (March 1st 2024 - March 1st 2025) 5. The daily average for the number of critical care (ICU) beds available for patients each month in the past 12 months (March 1st 2024 - March 1st 2025) 6. The number of instances of critical care (ICU) beds being unavailable due to staffing shortages for each year in the past 5 years (2021-2025)
Date of Response: 21/04/2025
View Response: 9899.pdf

Freedom of Information Request Reference: 9898
Date Received: 24/03/2025
Summary:
I am writing to inquire about the medical services your hospital offers for patients suffering from severe lung disease.
Date of Response: 14/04/2025
View Response: 9898.pdf

Freedom of Information Request Reference: 9897
Date Received: 24/03/2025
Summary:
I would like to determine whether Animal Assisted Therapies are offered within the trust/ service as treatments/interventions to NHS patients. I would like to determine how much is spent on these treatments/interventions. I would like to determine who offers these treatments, is it NHS clinicians, or other outside organisations and or volunteers.
Date of Response: 17/04/2025
View Response: 9897.pdf

Freedom of Information Request Reference: 9896
Date Received: 13/03/2025
Summary:
Request in relation to job application.
Date of Response: 11/04/2025
View Response: 9896.pdf

Freedom of Information Request Reference: 9895
Date Received: 21/03/2025
Summary:
Has your health board piloted self-sampling as a means of identifying cervical cancer in women?
Date of Response: 18/04/2025
View Response: 9895.pdf

Freedom of Information Request Reference: 9894
Date Received: 21/03/2025
Summary:
Would you please supply a copy of your current chaperone policy, if this policy is being updated or reviewed, please indicate this in your response?
Date of Response: 11/04/2025
View Response: 9894.pdf

Freedom of Information Request Reference: 9892
Date Received: 21/03/2025
Summary:
I am looking to find out information on the number of diagnostic radiographers employed by NHS Lothian at the start of 2025. This includes diagnostic radiographers working in all types of imaging modalities (e.g. x-ray, CT, MRI, ultrasound/sonography, mammography, nuclear medicine). I am specifically looking for data for February 2025 or the most up-to-date figures if data from February 2025 is not yet available. Questions How many diagnostic radiographers were employed by NHS Lothian in February 2025? How many diagnostic radiographers employed by NHS Lothian have been qualified for less than 1 year?
Date of Response: 17/04/2025
View Response: 9892.pdf

Freedom of Information Request Reference: 9891
Date Received: 21/03/2025
Summary:
How many patients have been treated for advanced (FIGO Stages III and IV) ovarian (epithelial ovarian, fallopian tube or primary peritoneal) cancer over the last 3 months? If none, do you refer advanced ovarian cancer patients to another trust, and if so which one? How many ovarian cancer patients (any stage) have been treated in the last 3 months with: Paclitaxel in combination with a platinum-based compound Platinum-based therapy alone (cisplatin or carboplatin) Bevacizumab in combination with paclitaxel and carboplatin Olaparib Olaparib + Bevacizumab Niraparib Rucaparib Does your trust participate in any clinical trials for the treatment of ovarian cancer? If so, please provide the name of each trial along with the number of patients taking part If data for HRD (homologous recombination deficiency) testing is available, please provide how many HRD positive patients were treated in the last 3 months with: Olaparib Olaparib + Bevacizumab Niraparib Other treatments
Date of Response: 17/04/2025
View Response: 9891.pdf

Freedom of Information Request Reference: 9890
Date Received: 18/03/2025
Summary:
I am looking for information regarding patients attending A&E for mental health reasons. As such, can I request the following for the calendar years 2019, 2020, 2021, 2022, 2023, 2024, 2025 (most recent) The number of patients, with an age breakdown, who have attended A&E due to mental health reasons? The number of patients, with an age breakdown, who have attended A&E due to self-harm or attempted suicide? The number of mental health patients, with an age breakdown, who are readmitted through A&E following a recent hospital discharge (within 7 days)?
Date of Response: 15/04/2025
View Response: 9890.pdf

Freedom of Information Request Reference: 9889
Date Received: 19/03/2025
Summary:
I would like to request an update on the Early Access Program EAP for Givinostat. What is the current status of the EAP for Givinostat (Duvyzat) treatment for DMD?
Date of Response: 16/04/2025
View Response: 9889.pdf

Freedom of Information Request Reference: 9887
Date Received: 19/03/2025
Summary:
Could you also please provide information in regards to NHS Lothian staff? please include requested data from the Royal Edinburgh Hospital, regarding staff who have been sacked for not wearing a face mask from date 01/01/2021 to present date. Please also include data for staff who have been sacked for not agreeing to the COV19 vaccine.
Date of Response: 16/04/2025
View Response: 9887.pdf

Freedom of Information Request Reference: 9885
Date Received: 19/03/2025
Summary:
1. Can you please provide the number of patients on the Unlicensed Sirolimus Ointment for the treatment of facial angiofibroma associated with tuberous sclerosis. 2. Out of the patients on the Unlicensed Sirolimus Ointment for the treatment of facial angiofibroma associated with tuberous sclerosis please could you let me know how many are on a dose of 0.1%, 0.2% and 0.5% .With a timeframe for any usage in 2024to date.
Date of Response: 16/04/2025
View Response: 9885.pdf

Freedom of Information Request Reference: 9884
Date Received: 19/03/2025
Summary:
Please provide the number of total cases for each illness reported within your trust between 2014 and 2024, broken down by year. The main questions and a) are a priority, but if it does not exceed the cost please also provide answers to b) (broken down by adults and children if possible). 1. How many cases of rickets were reported between 2014 and 2024 (please break down by year). a. How many of these cases were children (under 18)? b. Please provide the number of death certificates where rickets was listed as an underlying cause or a contributory factor in the last 10 years. 2. How many cases of tuberculosis were reported between 2014 and 2024 (please break down by year). a. How many of these cases were children (under 18)? b. Please provide the number of death certificates where tuberculosis was listed as an underlying cause or a contributory factor in the last 10 years. 3. How many cases of scurvy were reported between 2014 and 2024 (please break down by year). a. How many of these cases were children (under 18)? b. Please provide the number of death certificates where scurvy was listed as an underlying cause or a contributory factor in the last 10 years. 4. How many cases of malnutrition were reported between 2014 and 2024 (please break down by year). a. How many of these cases were children (under 18)? b. Please provide the number of death certificates where malnutrition was listed as an underlying cause or a contributory factor in the last 10 years. 5. How many cases of scarlet fever were reported between 2014 and 2024 (please break down by year). a. How many of these cases were children (under 18)? b. Please provide the number of death certificates where scarlet fever was listed as an underlying cause or a contributory factor in the last 10 years. 6. How many cases of syphilis were reported between 2014 and 2024 (please break down by year). a. How many of these cases were children (under 18)? b. Please provide the number of death certificates where syphilis was listed as an underlying cause or a contributory factor in the last 10 years. 7. How many cases of scabies were reported between 2014 and 2024 (please break down by year). a. How many of these cases were children (under 18)? b. Please provide the number of death certificates where scabies was listed as an underlying cause or a contributory factor in the last 10 years. 8. How many cases of whooping cough were reported between 2014 and 2024 (please break down by year). a. How many of these cases were children (under 18)? b. Please provide the number of death certificates where whooping cough was listed as an underlying cause or a contributory factor in the last 10 years 9. How many cases of measles were reported between 2014 and 2024 (please break down by year). c. How many of these cases were children (under 18)? c. Please provide the number of death certificates where measles was listed as an underlying cause or a contributory factor in the last 10 years
Date of Response: 16/04/2025
View Response: 9884.pdf

Freedom of Information Request Reference: 9883
Date Received: 19/03/2025
Summary:
The number of GPs in NHS Lothian who do not offer diabetes services as part of their services. The number of GPs who have opted out of diabetes services in the last 6 months.
Date of Response: 16/04/2025
View Response: 9883.pdf

Freedom of Information Request Reference: 9882
Date Received: 19/03/2025
Summary:
1) We have the following formularies listed as used by the organisation: East Region Formulary Please confirm if this is correct and if not, please provide any relevant online links or copies of formularies. 2) We understand the following committees maintain the formularies in question 1: East Region Formulary Committee NHS Borders, NHS Fife and NHS Lothian’s Area Drug and Therapeutics Committees (ADTCs) Please confirm if this is correct. If not correct, please list the relevant committees with the corresponding formulary. 3) Does the organisation have representation on the committees listed in question 2? 4) Are any of the above formularies listed in question 1 dominant when making prescribing decisions or does this depend on therapy area? Please say which is the dominant formulary of the organisation. 5) If you use a PDF formulary, have you considered moving it to an online platform like Netformulary, and if yes, when are you planning to do so? 6) Request for Re-use If your organisation does hold this information and is able to share it, then I would like to submit the following request for re-using the information:
Date of Response: 08/04/2025
View Response: 9882.pdf

Freedom of Information Request Reference: 9881
Date Received: 13/03/2025
Summary:
1. Is there any data on the prevalence and burden of chronic kidney disease available from your health board? 2. If so, how is it collected and what data is available?
Date of Response: 11/04/2025
View Response: 9881.pdf

Freedom of Information Request Reference: 9880
Date Received: 09/03/2025
Summary:
Who is the responsible person/service for the management of Ophthalmology dedicated phone number
Date of Response: 09/04/2025
View Response: 9880.pdf

Freedom of Information Request Reference: 9879
Date Received: 18/03/2025
Summary:
I am keen to understand how long patients are waiting for speech and language therapy. As such, for each financial year from 2019/20 to 2024/25 (most recent): 1. the total number of referrals for speech and language therapy, broken down by a) adult and b) children and young people? 2. both the median and longest wait from referral to an initial appointment/assessment, broken down by a) adult and b) children and young people? 3. both the median and longest wait from referral to starting treatment, broken down by a) adult and b) children and young people? 4. the total number of patients currently on a speech and language therapy waiting list, broken down by a) adult and b) children and young people?
Date of Response: 17/04/2025
View Response: 9879.pdf

Freedom of Information Request Reference: 9878
Date Received: 17/03/2025
Summary:
1. Does NHS Lothian require all GP practices operating in NHS premises to use health board telephony systems? 2. Are GP practices permitted to procure other technologies as an alternative to health board telephony systems? 3. With regard to the national BT switch from analogue to digital landlines, what efforts has the board made to ensure GP practices are aware that they do not require to install a new network and can use existing infrastructure to run cloud hosted telephony over? 4. If GPs are not allowed to use the existing network to run voice over, can the health board provide a reason this cannot be done via VLANs or segregation on the network? 5. What guidance has been provided to GP practices to support them to facilitate the switch in the most cost-effective and efficient manner? 6. Does NHS Lothian permit the recording of telephone calls between GP and patient? 7. If no, what assessment has been carried out of the potential benefits and risks of recording telephone conversations between GPs and patients? 8. What consideration has the board given to breaking down NHS buildings and services invoices to show telephony costs, providing greater transparency for GP practices regarding their expenses?
Date of Response: 14/04/2025
View Response: 9878.pdf

Freedom of Information Request Reference: 9877
Date Received: 08/03/2025
Summary:
Please include the following information for the following financial years: 2021/22, 2022/23, 2023/24, and 2024/25: • Total number of days lost due to sick leave taken by NHS Nurses • The total number of NHS nurses who took sick leave • Total number of days lost to Mental Health issues taken by NHS nurses • The total number of nurses who required sickness absence on mental health grounds • The number of NHS nurses taking more than seven days of absence without a sick note • The total number of days lost in excess of the seven days. • For example, if an individual has taken off 10 days without a sick note, then this would be 3 days in excess of the seven days
Date of Response: 14/04/2025
View Response: 9877.pdf

Freedom of Information Request Reference: 9876
Date Received: 17/03/2025
Summary:
Number of hospital admissions due to injuries caused by knife or bladed/pointed instrument/sharp objects in NHS Lothian broken down by area for the last three years, up to and including the latest available data.
Date of Response: 08/04/2025
View Response: 9876.pdf

Freedom of Information Request Reference: 9875
Date Received: 17/03/2025
Summary:
1. A breakdown of the number of NHS Lothian employees grouped by salary bands (e.g., £50,000–£55,000, £55,001–£60,000, etc.). 2. The number of NHS Lothian employees whose annual salary is £50,000 or higher. 3. The number of NHS Lothian employees whose annual salary is £80,000 or higher. 4. The number of NHS Lothian employees whose annual salary is £100,000 or higher.
Date of Response: 14/04/2025
View Response: 9875.pdf

Freedom of Information Request Reference: 9874
Date Received: 17/03/2025
Summary:
The number of unfilled clinical psychologists vacancies in NHS Lothian and what percentage of Clinical Psychologist vacancies are filled, meeting minutes where the financial burden of employing clinical psychologists was discussed in deciding the number of posts, and total spending on Trainee and Full Clinical Psychologists. Date range: Jan 1 2024- 14 March 2025
Date of Response: 14/04/2025
View Response: 9874.pdf

Freedom of Information Request Reference: 9873
Date Received: 17/03/2025
Summary:
Please provide me with the number of weight loss medication prescriptions which have been issued since 2022. Please provide stats by year. Please provide a breakdown of the various medications prescribed, including, but not limited to, Liraglutide (Saxenda®), Semaglutide (Wegovy®) and Tirzepatide.
Date of Response: 08/04/2025
View Response: 9873.pdf

Freedom of Information Request Reference: 9872
Date Received: 17/03/2025
Summary:
1. The numbers of patients who underwent surgery to repair an abdominal aortic aneurysm at the Edinburgh Royal Infirmary in years 2022, 2023 and 2024. 2. Of that yearly patient cohort the number who died within the 3, 6 and 12 month post op periods. 3. Of that yearly patient cohort how many experienced a spinal cord injury as a result of their surgery.
Date of Response: 08/04/2025
View Response: 9872.pdf

Freedom of Information Request Reference: 9871
Date Received: 14/03/2025
Summary:
I request details of any defective, unused, or written-off medical equipment purchased over the last five years, including: 1. The total value of medical equipment that was found to be defective or unfit for use. 2. A list of the defective or unused equipment, including: o The type of equipment o The supplier/manufacturer o The cost o The reason it was not used or found defective 3. Any costs associated with storage, maintenance, or disposal of this equipment.
Date of Response: 11/04/2025
View Response: 9871.pdf

Freedom of Information Request Reference: 9870
Date Received: 14/03/2025
Summary:
I request details of all spending on external consultants over the last five years, including: 1. The total amount spent each year on external consultancy services. 2. A list of all consultancy contracts awarded, including: o The name of the consultancy firm o The purpose of the contract o The cost of each contract o The outcome or deliverables provided
Date of Response: 09/04/2025
View Response: 9870.pdf

Freedom of Information Request Reference: 9868
Date Received: 14/03/2025
Summary:
Can you confirm if you still have an available pathway for diagnosis of adult Autism and ADHD? What criteria do you have for someone to be referred for diagnosis?
Date of Response: 11/04/2025
View Response: 9868.pdf

Freedom of Information Request Reference: 9866
Date Received: 13/03/2025
Summary:
Q.1 How many patients under the age of 18-years-old have received Electroconvulsive therapy in the past ten years, could you please provide this in a breakdown of financial years? Q.2 Could you please provide the total number of Electroconvulsive therapy session were used for under 18s in the past ten years, could you please provide this in a breakdown of financial years? To clarify, by session I am referring to each time ECT was used not the number of blocks. Q.3 What is the total number of adverse events recorded on DATIX as a result of ECT in under 18s in the past 10 years. Can you please provide this in a breakdown of the past ten financial years?
Date of Response: 10/04/2025
View Response: 9866.pdf

Freedom of Information Request Reference: 9865
Date Received: 13/03/2025
Summary:
Can I request the following information broken down by the calendar year for 2021, 2022, 2023, 2024, and 2025 (most recent as of this email). 1. How many X-Ray scanners have had an error, fault, or needed any non-planned engineer work? a. How many cumulative/total hours of X-Ray downtime has been caused by these issues ? 2. How many CT scanners have had an error, fault, or needed any non-planned engineer work a. How many cumulative/total hours of CT downtime has been caused by these issues? 3. How many MRI scanners have had an error, fault, or needed any non-planned engineer work a. How many cumulative/total hours of MRI downtime has been caused by these issues?
Date of Response: 02/04/2025
View Response: 9865.pdf

Freedom of Information Request Reference: 9864
Date Received: 13/03/2025
Summary:
Regarding policy surrounding surgical referrals made by clinicians at Chalmers Gender Identity Clinic in Edinburgh. 1. Is there any pause or restriction on patients being referred for surgery currently in effect? 2. Has there been any such pause or restriction in effect since 1 January 2024? 3. If the answer to 1 or 2 is yes, please provide the start and (if applicable) end date or expected end dates for the pause or restriction. 4. If the answer to 1 or 2 is yes, please provide all communications, minutes, agendas and policy documents which include mention of the pause or restriction, from a time period of six months before the start of the pause or restriction to the present day.
Date of Response: 09/04/2025
View Response: 9864.pdf

Freedom of Information Request Reference: 9863
Date Received: 09/03/2025
Summary:
The amount of funds spent by the Health Board to deliver the National Dental Inspection Programme in 2024-25 to date. The amount of funds spent by the Health Board to deliver the National Dental Inspection Programme for the four previous financial years.
Date of Response: 21/03/2025
View Response: 9863.pdf

Freedom of Information Request Reference: 9862
Date Received: 09/03/2025
Summary:
The number of delayed discharges in 2024/25 resulting from issues of patients who lack capacity but do not have a person appointed with the Power of Attorney.
Date of Response: 09/04/2025
View Response: 9862.pdf

Freedom of Information Request Reference: 9861
Date Received: 12/03/2025
Summary:
1. How many care homes are operated by the NHS in your health board? 2. How care homes, operated by the NHS in your health board, have closed in the last five years? (please can you split this up by year). 3. How many care homes, operated by the NHS in your health board, have temporarily closed in the last five years? (please can you split this up by year). 4. Could you provide any information on the reasons for why those homes were closed or temporarily closed?
Date of Response: 09/04/2025
View Response: 9861.pdf

Freedom of Information Request Reference: 9859
Date Received: 12/03/2025
Summary:
I would like to request the following data: •The current average waiting time for an initial autism assessment appointment in your health board area. •The number of adult referrals from GPs for an initial autism assessment in 2024, broken down by gender.
Date of Response: 04/04/2025
View Response: 9859.pdf

Freedom of Information Request Reference: 9858
Date Received: 01/03/2025
Summary:
Q1. Please provide the total number of patients treated in the last 6 months for: •Polycythaemia Vera (ICD10 code D45) •Myelofibrosis (ICD10 code D47.4) •Myelofibrosis (ICD10 code D47.4) patients aged 65 and older Q2. How many patients were treated in the past 6 months (for any disease) with: •Ruxolitinib •Fedratinib •Momelotinib Q3. How many patients were treated with Ruxolitinib in the past 6 months for the following diseases? •Myelofibrosis (ICD10 code D47.4) •Polycythaemia Vera (ICD10 code D45) •Other/Unknown Q4. How many myelofibrosis (ICD10 code D47.4) patients has your trust diagnosed in the past 3 years? •Of these patients, how many were treated in the past 6 months with Hydroxycarbamide? •Of these patients, how many were treated in the past 6 months with Interferon therapy? •Of these patients, how many have received no active treatment in the past 6 months? Q5. Does your trust participate in any clinical trials for the treatment of myelofibrosis? If so, can you please provide the name of each trial along with the number of patients taking part.
Date of Response: 07/04/2025
View Response: 9858.pdf

Freedom of Information Request Reference: 9857
Date Received: 11/03/2025
Summary:
I would be grateful if you could provide me with a hard copy of NHS Lothian's extravasation policy and procedure as in force on 5 March 2024.
Date of Response: 08/04/2025
View Response: 9857.pdf

Freedom of Information Request Reference: 9856
Date Received: 11/03/2025
Summary:
Q1. In the past 3 months, how many patients have received the following treatments (for any disease): • Berinert (Human C1-esterase inhibitor) • Cinryze (Human C1-esterase inhibitor) • Firazyr (Icatibant) • Icatibant - any brand except Firazyr • Orladeyo (Berotralstat) • Ruconest (Recombinant human C1-esterase inhibitor) • Takhzyro (Lanadelumab) • Garadacimab (Andembry) Q2. In the past 3 months how many patients have received the following immunoglobulin treatments (for any disease): • Cutaquig • Cuvitru • Gammagard • Gammanorm • Hizentra • Hyqvia • Intratect • Iqymune • Kiovig • Privigen • Octagam • Panzyga • Subgam • Any other normal immunoglobulin
Date of Response: 04/04/2025
View Response: 9856.pdf

Freedom of Information Request Reference: 9855
Date Received: 11/03/2025
Summary:
Can I request the following, broken down by the calendar years 2019, 2023, 2024 and 2025 (most recent): 1. The median wait (in days) between the initial meeting (assessment/choice appointment), where a CAMHS professional will talk to the child or young person who is unwell, listen to their symptoms and decide on how to help them, and the start of treatment. 2. The longest wait (in days) between the initial meeting (assessment/choice appointment), where a CAMHS professional will talk to the child or young person who is unwell, listen to their symptoms and decide on how to help them, and the start of treatment.
Date of Response: 11/04/2025
View Response: 9855.pdf

Freedom of Information Request Reference: 9854
Date Received: 11/03/2025
Summary:
1. How many pharmacists are registered as Independent Prescribers (IP’s) in your Health Board? 2. How does your Health Board assess if a prescriber is active or not? 3. How many pharmacists are registered as active Independent Prescribers (IP’s) in your Health Board? 4. How many pharmacist Independent Prescribers (IP’s) are actively working within each sector in your Health Board? Please specify sector and number of prescribers within each. Sector Number of active Pharmacist IP's Hospital inpatient Hospital outpatient GP practices Community pharmacies Other (please specify sector) 5. What therapeutic/clinical areas are pharmacist Independent Prescribers (IP’s) practising within? Please specify number of pharmacist IP’s within each therapeutic/clinical area. Therapeutic/Clinical Area Number of active Pharmacist IP's Cardiovascular (hypertension, heart failure, ischaemic heart disease, dyslipidaemia) Common clinical conditions (respiratory tract, ENT, skin, UTI) Endocrinology (thyroid dysfunction, diabetes mellitus) Gastrointestinal (peptic ulcer disease, gastro-oesophageal reflux disease, inflammatory bowel disease) Musculoskeletal (osteoarthritis, rheumatoid arthritis, pain) Neurology (Alzheimer’s disease, epilepsy, Parkinson’s) Oncology (general aspects, breast cancer, colorectal cancer, lung cancer) Psychiatry (affective disorders, anxiety and sleep, schizophrenia) Respiratory (asthma, chronic obstructive pulmonary disease) Women’s Health (HRT, menstrual, endometriosis) Non-specialist (general practice across multiple sectors) Other (please specify therapeutic area) 6. How many pharmacists in your Heath Board are currently undertaking independent prescribing training? 7. How many pharmacists in your Health Board are waiting to access independent prescribing training?
Date of Response: 04/04/2025
View Response: 9854.pdf

Freedom of Information Request Reference: 9852
Date Received: 11/03/2025
Summary:
Can you tell me what criteria is used or what the reason could be for shorter wait time to see a consultant which resulted in a referral to the waiting list 2 months before me? We are both part of NHS Lothian albeit living in different council areas. What is the average wait time from GP referral to the point of being added to the waiting list for hip replacement by council area within NHS Lothian? What is the criteria which determines the waiting time for an orthopaedic consultation? Why would it be different in some cases?
Date of Response: 04/04/2025
View Response: 9852.pdf

Freedom of Information Request Reference: 9851
Date Received: 12/03/2025
Summary:
Question One Do you treat patients for Urothelial cancer (Yes or No)? If No, where do you refer patients for treatment Question Two How many patients were treated for Urothelial cancer (any stage) in the past 3 months with the following treatments: Atezolizumab (Tecentriq) Avelumab (Bavencio) Carboplatin single agent or in any other combination Carboplatin with Gemcitabine Carboplatin with Gemcitabine + Avelumab (Bavencio) Carboplatin with Paclitaxel Cisplatin single agent or in any other combination Cisplatin with Gemcitabine Cisplatin with Gemcitabine + Nivolumab (Opdivo) Cisplatin with Gemcitabine + Avelumab (Bavencio) Enfortumab Vedotin + Pembrolizumab (Padcev + Keytruda) Nivolumab (Opdivo) Pembrolizumab (Keytruda) Other active systemic anti-cancer therapy Palliative care only Erdafitinib Question Three How many patients have been treated for metastatic Urothelial cancer in the past 3 months with the following systemic anti-cancer therapies: Carboplatin single agent or in any other combination Carboplatin with Gemcitabine Carboplatin with Gemcitabine + Avelumab (Bavencio) Carboplatin with Paclitaxel Cisplatin single agent or in any other combination Cisplatin with Gemcitabine Cisplatin with Gemcitabine + Avelumab (Bavencio) Question Four Does your trust participate in any ongoing clinical trials for the treatment of urothelial cancer? If so, can you please provide the name of each trial along with the number of patients taking part?
Date of Response: 04/04/2025
View Response: 9851.pdf

Freedom of Information Request Reference: 9818
Date Received: 04/03/2025
Summary:
How many people have left the waiting lists for hip or knee replacements in each year since 2020 (by calendar year) and for what reason? This means, a person was on the waiting list but left it or was removed before getting a procedure. Please separate the data by each procedure.
Date of Response: 17/04/2025
View Response: 9818.pdf

Freedom of Information Request Reference: 9850
Date Received: 10/03/2025
Summary:
I would be grateful if you could provide the following information for the most recent financial year available: 1. The total spending by the ICB on outpatient psychiatry appointments. 2. The average cost per assessment/appointment for the following outpatient psychiatry services: - ADHD assessments - Autism Spectrum Disorder (ASD) assessments - General mental health assessments - Drug and alcohol assessments - Child psychiatry assessments - Follow-up psychiatry appointments 3. If available, a breakdown of the above costs distinguishing between assessments carried out by NHS providers and those commissioned from private providers.
Date of Response: 02/04/2025
View Response: 9850.pdf

Freedom of Information Request Reference: 9849
Date Received: 10/03/2025
Summary:
I would like to put in a Freedom of information request for all notes of interest for pharmacies in Lothian. I would also like to know the exact location/area of each note of interest. I would also like to request the timeline for each note of interest i.e timeline for when they will proceed to pre application meeting.
Date of Response: 07/04/2025
View Response: 9849.pdf

Freedom of Information Request Reference: 9848
Date Received: 10/03/2025
Summary:
I am writing to formally request information regarding communication systems used by NHS Lothian for communicating with patients not attending face-to-face outpatient appointments. The information requested is as follows : - 1. Policy and Procedure - Please provide a copy of NHS Lothian’s current policy and procedure on the use of telephone and online appointments, including video call systems. - Please confirm the name of all video call systems currently in use by NHS Lothian e.g. Microsoft Teams, Near Me etc. 2. Near Me system • When was the Near Me video call system first introduced in NHS Lothian? • What training programs or resources have been provided to staff to ensure they are adequately trained in using the Near Me system? • How is the effectiveness of this training evaluated? • Is there ongoing training or support systems in place for new staff and/or to provide refresher training? 3. Challenges and Lessons Learned • What have been the biggest challenges in implementing and adopting the Near Me system within NHS Lothian? 4. Staff Engagement and Buy-In • How was staff engagement ensured during the planning and implementation phases of the Near Me system? • Is there universal buy-in from all staff (including medical staff, nursing staff, admin. Staff etc) regarding the use of the Near Me system? If not, what are the main concerns or resistance points? • Have staff reported any challenges or barriers in using the Near Me system, and how have these been addressed? 4. Exemptions • - Are all departments expected to offer patients a consultation via Near Me, where the same appointment is able to offered as a telephone option for the same consultation? • Are there any outpatient departments within NHS Lothian that are currently allowed to not use video call systems, where a telephone appointment can be made available? • If so, please list these departments and provide the rationale for this exemption. 5. Principles of Use • What were the primary drivers or motivations for adopting the Near Me system within NHS Lothian? • What are NHS Lothian’s principles for using telephone and online appointment systems, particularly in relation to ensuring accessibility for disabled people and those who are unemployed? • Are there any specific measures in place to support these groups in accessing appointments via these systems? 6. Online Information - Please provide links to any information available online about NHS Lothian’s use of telephone and online appointment systems, including video calls.
Date of Response: 07/04/2025
View Response: 9848.pdf

Freedom of Information Request Reference: 9847
Date Received: 10/03/2025
Summary:
• How many Osteotomies have been conducted within your Health Board over the last five years. • What is the average length of wait for such a procedure within this time period? • What are the number of Osteotomies conducted as a result of broken bones which have been left untreated (i.e., how many Osteotomies are conducted on people who have recent - say in the last three years - previous broken bones).
Date of Response: 08/04/2025
View Response: 9847.pdf

Freedom of Information Request Reference: 9846
Date Received: 10/03/2025
Summary:
Q1. How many early-stage (non-metastatic or Stages 1-3) non-small cell lung cancer (NSCLC) patients were treated in the past 3 months with: •Atezolizumab (Tecentriq) •Durvalumab (Imfinzi) •Nivolumab (Opdivo) •Pembrolizumab (Keytruda) •Chemotherapy •Radiotherapy •Chemotherapy AND Radiotherapy •Osimertinib Q2. How many patients were treated in the past 3 months for gastric cancer (any stage) with: •CAPOX (Capecitabine with Oxaliplatin) •FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin) •Lonsurf (Trifluridine - tipiracil) •Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) •Pembrolizumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) •Any other systemic anti-cancer therapy •Palliative care only •Zolbetuximab (Vyloy) Q3 How many patients were treated in the past 3 months for cancer of the gastro-oesophageal junction (any stage) with: •CAPOX (Capecitabine with Oxaliplatin) •FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin) •Lonsurf (Trifluridine - tipiracil) •Nivolumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) •Pembrolizumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) •Zolbetuximab (Vyloy) •Any other systemic anti-cancer therapy •Palliative care only Q4 How many patients were treated in the last 3 months with any systemic anti-cancer therapies for Gastric cancer or cancer of the Gastro-Oesophageal Junction? Q5. How many patients has your trust treated in the last 3 months with Pembrolizumab for stage II Melanoma?
Date of Response: 04/04/2025
View Response: 9846.pdf

Freedom of Information Request Reference: 9844
Date Received: 07/03/2025
Summary:
Questionnaire related to wound care.
Date of Response: 04/04/2025
View Response: 9844.pdf

Freedom of Information Request Reference: 9843
Date Received: 06/03/2025
Summary:
I require you to review your response.
Date of Response: 09/04/2025
View Response: 9843.pdf

Freedom of Information Request Reference: 9845
Date Received: 07/03/2025
Summary:
How many individuals are currently open to NHS Lothian's Forensic Community Mental Health Team? Of those currently open to the team, how many are aged 50 or older?
Date of Response: 09/04/2025
View Response: 9845.pdf

Freedom of Information Request Reference: 9842
Date Received: 06/03/2025
Summary:
1. In each year since 2019-20, including the current year to date, in this health board, how many patients have been directed or referred to hospitals or other healthcare settings (clinics/primary care centres etc) in another health board? 2. In relation to Q1, what was the furthest transfer in miles? 3. In relation to Q1, is there a cost associated with this?
Date of Response: 09/04/2025
View Response: 9842.pdf

Freedom of Information Request Reference: 9841
Date Received: 06/03/2025
Summary:
• What hospitals are a part of your Trust / Health Board? • Do any of these have Pathology Labs and if so which? • Which of the National Pathology Networks do you belong to? • Do you partner with any other Labs to work collectively? • What Laboratory Information Management systems (LIMS / LIS) do you use? • Do you have a Single instance / Pathology Network Wide LIS / LIMS solution? • When is the contract for your LIS / LIMS due to run out? • Do you have a Blood Transfusion Laboratory at any of your locations and if so which? • Do you have an Electronic Blood Tracking solution? • Do you have a dedicated Transfusion Lab LIS / LIMS and if so which? • Do you have anyone leading on Digital Transformation projects and if so who (if not able to state a name, what is their Role / Job title)?
Date of Response: 03/04/2025
View Response: 9841.pdf

Freedom of Information Request Reference: 9840
Date Received: 06/03/2025
Summary:
1. How much has your organisation spent on measures relating to Equality, Diversity and Inclusion in each year since 2019-20? 2. In relation to Q1, please provide as much information on what this money has been spent on?
Date of Response: 01/04/2025
View Response: 9840.pdf

Freedom of Information Request Reference: 9839
Date Received: 06/03/2025
Summary:
Please can you send me: • A copy of the guidelines for GPs to refer patients with suspected ILD to specialist respiratory services. • A copy of your board’s ILD diagnosis pathway. • Information about ILD MDT meetings held by clinicians in your Board areas, including: o Which professionals attend ILD MDT meetings. o The schedule for holding of ILD MDT meetings. o The number of patients considered at each ILD MDT meeting. o The number of patients marked “suspected ILD” who have been referred to an ILD MDT in each of the past three years. • The number of the following healthcare professionals currently working in the health board, and the site where they are based: o medical consultants and registrars with stated specialism in ILD (including but not limited to radiology and respiratory) o ILD specialist nurses o ILD specialist pharmacists o ILD specialist physiotherapists • The number of antifibrotic prescriptions initiated for patients living in your NHS board areas in each of the last three years.
Date of Response: 03/04/2025
View Response: 9839.pdf

Freedom of Information Request Reference: 9838
Date Received: 05/03/2025
Summary:
For the last three years, where data is available, please could you confirm the following: 1. The total amount spent by the board on providing a public dental service, broken down by year. 2. The number of full time equivalent dentists employed by the health board to provide PDS, broken down by year. 3. The number of proceduress carried out by the PDS, broken down by year, if known. 4. The number of patients treated by the PDS, broken down by year, if known. 5. Details of the locations where PDS services are currently provided. 6. The number of referrals and waiting list size, broken down by year, if known.
Date of Response: 02/04/2025
View Response: 9838.pdf

Freedom of Information Request Reference: 9837
Date Received: 05/03/2025
Summary:
I would like to request information regarding your obstetric unit(s) in your NHS board, under the FOIA, -Is your Hospital a tertiary Fetal Medicine Unit? -Does your Hospitals do a routine late third trimester scan for every woman in pregnancy? Regarding growth scans in the second or third trimester: -To calculate HC do you use HC or BPD + OFD? -To calculate AC do you use AC or TAPD + APD? -To plot FL centile which biometry chart do you use? (eg Chitty ) -To plot HC centile which biometry chart do you use? (eg Chitty ) -To plot AC centile which biometry chart do you use? (eg Chitty ) -What algorithm do you use to calculate Estimated Fetal Weight? (Eg Hadlock (HC, AC, FL), Hadlock (BPD-HC-AC-FL), Hadlock (FL-AC), Warsof (BPD-AC), Persson (BPD-TAD-APAD-FL), Hansmann et al, Combs, Souka, INTERGROWTH-21ST or other) -What centile reference chart do you use to plot the Estimated Fetal Weight? -Does your trust use GAP-GROW? -To measure Amniotic Fluid does your trust measure Deepest Vertical Pool or measure Amniotic Fluid Index? -Which chart do you use to plot the amniotic fluid volume? -When measuring Uterine Artery Doppler PI and PSV which reference centile chart do you use? -When measuring Umbilical Artery Doppler PI and PSV which reference centile chart do you use? -When measuring Middle Cerebral Artery Doppler PI and PSV which reference centile chart do you use? -When measuring Ductus Venosus Doppler PI and PSV which reference centile chart do you use?
Date of Response: 02/04/2025
View Response: 9837.pdf

Freedom of Information Request Reference: 9836
Date Received: 05/03/2025
Summary:
Q1. Does your trust provide SACT (systemic anti-cancer therapy) treatments for endometrial cancer? If not, which other trust do you refer endometrial cancer patients to for SACT treatments? Q2. How many patients were treated for endometrial cancer (any stage) in the past three months with the following treatments: •Dostarlimab (Jemperli) •Dostarlimab (Jemperli) AND Chemotherapy •Hormone therapy (Progesterone or Letrozole) •Pembrolizumab (Keytruda) monotherapy •Lenvatinib + Pembrolizumab (Lenvima +Keytruda)  •Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide) •Any other SACT •Any other Chemotherapy •Durvalumab with platinum-based chemotherapy •Pembrolizumab with platinum-based chemotherapy Q3. In the past three months, how many patients were treated for recurrent endometrial cancer after having previously received platinum-based chemotherapy? Q4. In the past three months, how many patients were treated for endometrial cancer with the following as first line treatments: •Dostarlimab (Jemperli) AND Chemotherapy •Durvalumab with platinum-based chemotherapy •Pembrolizumab with platinum-based chemotherapy •Hormone therapy (Progesterone or Letrozole) •Platinum-based chemotherapy (monotherapy or combination with taxanes, anthracyclines, cyclophosphamide) •Any other SACT •Any other chemotherapy Q5. Does your trust participate in any clinical trials for the treatment of endometrial cancer? If so, can you please provide the name of each trial and the number of patients taking part.
Date of Response: 02/04/2025
View Response: 9836.pdf

Freedom of Information Request Reference: 9831
Date Received: 05/03/2025
Summary:
1. The number of audiology staff employed by the board in 2022, 2023, 2024 and 2025 to date. 2. The number of people placed on an audiology appointment waiting list in 2022, 2023, 2024 and 2025 to date. 3. The a/ average and b/ longest waiting times for the audiology service in 2022, 2023, 2024 and 2025 to date.
Date of Response: 15/04/2025
View Response: 9831.pdf

Freedom of Information Request Reference: 9804
Date Received: 28/02/2025
Summary:
I wish to make a Freedom of Information Request for the organisations single sex patient changing, toilet & showering policy.
Date of Response: 15/04/2025
View Response: 9804.pdf

Freedom of Information Request Reference: 9834
Date Received: 05/03/2025
Summary:
I wish to raise a Freedom of Information Request to cover Hospital guidance/training to staff on POAs Please advise what training/guidance is provided to staff regarding the recording of a Power of Attorney (POA) when approached by a relative/friend of a patient with the necessary POA authority. In addition, is there any additional training/guidance provided for POAs with non standard clauses e.g. when the POA document gives the Attorney the authority to declare the patient as no longer having capacity?
Date of Response: 02/04/2025
View Response: 9834.pdf

Freedom of Information Request Reference: 9833
Date Received: 05/03/2025
Summary:
1. Please provide the number of people waiting for an NHS assessment for ADHD and ADD in Edinburgh, Midlothian, West Lothian, and East Lothian a. Please break this down by number in each council area b. Please also provide the number of people on the waitlist at the end of each calendar year from 2019 to 2024 c. Please break down whether the person is waiting for an ADHD or ADD assessment. 2. Please provide the current estimated wait time (in years) for each council area. 3. How many NHS assessments for ADHD are being carried out each year in Edinburgh, Midlothian, West Lothian, and East Lothian? a. Please break this down by the number of assessments carried out each year in each area from 2019-2024 (inclusive).
Date of Response: 07/03/2025
View Response: 9833.pdf

Freedom of Information Request Reference: 9832
Date Received: 05/03/2025
Summary:
1. A copy of the the Orgnanisation's governance guidance document(s) regarding training of all employees in data protection and patient confidentiality. I understand this may have changed over time, please provide any documents showing changes or updates in the last 10 years, where that date range is not possible please provide what you can and clarify reasons why unable to provide more historical data (for example if this is due to a data retention policy then please include a copy of that data retention policy). 2. Information from the Organisation detailing the titles of roles (both clinical and non-clinical) and the data protection training and patient confidentiality training. For each role can you detail: a) expectations on candidates for employment and b) the frequency of renewal/refresh of such training for that title/role. If you do not have specific data, could you provide information on the general areas of roles... such as 'Nurses', 'Consultants', 'Surgeons', 'Secretary non-clinical', 'Payroll', etc, etc. This may have changed from year to year, over time - if this has changed significantly in the last 10 years, please advise of the date when changes were brought in and any associated documents regarding the change. 3. Information from the Organisation detailing the total number of staff and the percentage of adherence to completion of regular (annual?) renewal of data protection and patient confidentiality training. Please show as a trend over a number of years (annual aggregation is acceptable which shows the total staff and adherence/compliance data), Please provide data for the last 10 years, if unable to satisfy then provide it as far back as you can with a note on why additional historical data is not held (retention policy - then please quote the retention policy document). 4. Information from the Organisation regarding the number of data breaches. Grouped by those reported to the ICO (Information Commissioners Office) and those not reported to the ICO but reported internally to the organisation. If you could also provide within that data the severity that a breach was considered to be (e.g. Low, Medium, High). Additionally if any financial fines needed to be paid by the organisation, or other sanctions/enforcement actions made by the ICO or other regulatory body as a result of the breach. Please provide data for the last 10 years, if unable to satisfy then provide it as far back as you can with a note on why additional historical data is not held (retention policy - then please quote the retention policy document) 5. Please advise if your Organisation is asked to report on compliance with data protection training / patient confidentiality to a parent body or other organisation.
Date of Response: 02/04/2025
View Response: 9832.pdf

Freedom of Information Request Reference: 9830
Date Received: 05/03/2025
Summary:
I am aware NHS Lothian holds the HEPMA data recording system that The State Hospital is able to access. Please tell me for each year from 2019 to 2025: • How many PRNs were administered to the non-learning disabled/autistic population of The State Hospital? • How many of these were doses of benzodiazepines? • How many PRNs were administered to the -learning disabled/autistic population of The State Hospital? • How many of these were doses of benzodiazepines?
Date of Response: 01/04/2025
View Response: 9830.pdf

Freedom of Information Request Reference: 9829
Date Received: 05/03/2025
Summary:
Request in relation to personal information.
Date of Response: 26/03/2025
View Response: 9829.pdf

Freedom of Information Request Reference: 9828
Date Received: 04/03/2025
Summary:
I am seeking the number of referrals made to the CWIC mental health service in Haddington from 1st April 2020 to 1st April 2025.
Date of Response: 08/04/2025
View Response: 9828.pdf

Freedom of Information Request Reference: 9825
Date Received: 04/03/2025
Summary:
Stool Tests: 1. Are a) quantitative faecal immunochemical test and b) faecal calprotectin tests available in primary care in your area and for what indications? 2. If they are not available, please list the area(s) where faecal calprotectin tests is unavailable. Diagnostic Pathways: 3. How many diagnostic pathways do you currently have for patients presenting with Lower gastrointestinal symptoms? 4. Please can you list the titles of the pathways 5. Which of these pathways include the usage of faecal calprotectin test?
Date of Response: 01/04/2025
View Response: 9825.pdf

Freedom of Information Request Reference: 9824
Date Received: 04/03/2025
Summary:
I would like to request the following information regarding the ophthalmology services and IT systems used within your Trust: Ophthalmology Department & IT Record System 1. Does your Trust have an ophthalmology department and/or provide ophthalmology clinics? 2. If so, what is the name of the principal IT record system used to document results from patient consultations within ophthalmology? Imaging Capabilities & System Integration 3. Does the principal IT system allow clinicians to view images from scans conducted during a clinic visit? 4. Are there any types of medical images that cannot be imported into this principal IT system? If so: • What is the name of the IT programme used by clinicians to view these images? • What is the name of the scan/modality that generates these images? Data Integration with National Systems 5. Does the principal IT system integrate with the NHS Spine or other national patient record systems (e.g., OpenEyes, Medisoft, Epic)? 6. Does the system support the exchange of structured data with other NHS Trusts or external healthcare providers? Patient Access & Communication 7. Does the system allow patients to access their ophthalmology records, including images, via the NHS App or another patient portal? 8. Are there any restrictions on how imaging data can be shared with patients and external providers? Image Storage & Viewing Capabilities 9. What is the storage capacity and retention policy for ophthalmology-related imaging within the IT system? 10. If images are not viewable within the principal IT system, does the Trust use a separate PACS (Picture Archiving and Communication System) for ophthalmology imaging? Future IT Developments & Interoperability 11. Is the Trust planning any upgrades or changes to its ophthalmology IT infrastructure in the next five years? 12. Are there known interoperability challenges that affect the transfer of ophthalmology data within the Trust or between NHS organizations?
Date of Response: 09/04/2025
View Response: 9824.pdf

Freedom of Information Request Reference: 9823
Date Received: 04/03/2025
Summary:
Please see the below with regard to the Astley Ainslie move to Haddington. When did discussions about relocating patients start? Who within NHS Lothian knew about this relocation?
Date of Response: 09/04/2025
View Response: 9823.pdf

Freedom of Information Request Reference: 9814
Date Received: 04/03/2025
Summary:
BREAST CANCER Q1. How many patients were treated in total, regardless of diagnosis, with the following medicines in the 3 months between the start of October 2024 to the end of December 2024, or latest 3-month period available? 1.1 Abemaciclib (Verzenios) 1.2 Alpelisib (Piqray) 1.3 Elacestrant (Orserdu) 1.4 Fulvestrant (fulvestrant or Faslodex) 1.5 Inavolisib (Inaqovi) 1.6 Palbociclib (Ibrance) 1.7 Ribociclib (Kisqali) 1.8 Capivasertib (Truqap) 1.9 Talazoparib (Talzenna) 1.10 Olaparib (Lynparza) Q2. How many patients received the following medicines for early breast cancer in the 3 months between the start of October 2024 to the end of December 2024, or latest 3-month period for which data are available? 2.1 Abemaciclib (Verzenios) 2.2 Ribociclib (Kisqali) 2.3 Olaparib (Lynparza) Q3. How many patients received the following medicines with curative treatment intent in the 3 months between the start of October 2024 to the end of December 2024, or latest 3-month period for which data are available? 3.1 Abemaciclib (Verzenios) 3.2 Ribociclib (Kisqali) Q4. How many patients were treated with the following medicines in combination with fulvestrant in the 3 months between the start of October 2024 to the end of December 2024, or latest 3-month period available? 4.1 Abemaciclib (Verzenios) + Fulvestrant (fulvestrant or Faslodex) 4.2 Palbociclib (Ibrance) + Fulvestrant (fulvestrant or Faslodex) 4.3 Ribociclib (Kisqali) + Fulvestrant (fulvestrant or Faslodex) Q5. How many patients were treated with Olaparib (Lynparza) for the following types of breast cancer in the 3 months between the start of October 2024 to the end of December 2024? 5.1 All types of breast cancer 5.2 Locally advanced or metastatic breast cancer ENDOMETRIAL CANCER Q6. How many patients were treated for Endometrial Cancer, with the following medicines in the 3 months between 1st October 2024 and 31st December 2024, or latest 3-months for which data are available? 6.1 Dostarlimab (Jemperli) 6.2 Pembrolizumab (Keytruda) 6.3 Lenvatinib (Lenvima) Q7. How many patients were treated for Endometrial Cancer, with the following medicines as monotherapy or in combination, in the 3 months between 1st October 2024 and 31st December 2024, or latest 3-months for which data are available? 7.1 Dostarlimab monotherapy 7.2 Dostarlimab in combination with Chemotherapy 7.3 Pembrolizumab monotherapy 7.4 Pembrolizumab + Lenvatinib in combination 7.5 Lenvatinib monotherapy
Date of Response: 25/03/2025
View Response: 9814.pdf

Freedom of Information Request Reference: 9780
Date Received: 24/02/2025
Summary:
1. Does your Health Board have a patient flow system? 2. If so, is it using the electronic patient record, Or the national offer built on Palantir/Foundry? 3. Or does the Health Board have a specialist flow product? If so, what is the • Supplier name • System name • Contract expiry date
Date of Response: 09/04/2025
View Response: 9780.pdf

Carer Positive Icon
Awards Aware Icon
We are a Living wage Employer Icon
Duke of Edinburgh's Award Logo
Young Person's Guaranteed Employer Logo
Scottish Top Employers Logo
Disability Confident Employer Logo